10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 2 filers reported holding 10X GENOMICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $164,400,637 | -28.5% | 3,985,470 | -3.3% | 0.56% | -21.6% |
| Q2 2023 | $230,075,821 | +10.3% | 4,120,269 | +10.2% | 0.71% | +3.9% |
| Q1 2023 | $208,530,077 | +178352.0% | 3,737,768 | +16.6% | 0.69% | +55.8% |
| Q4 2022 | $116,855 | -99.9% | 3,206,783 | -5.4% | 0.44% | +21.8% |
| Q3 2022 | $96,581,000 | -39.5% | 3,391,177 | -3.8% | 0.36% | -34.4% |
| Q2 2022 | $159,591,000 | -34.5% | 3,526,878 | +10.2% | 0.55% | -1.4% |
| Q1 2022 | $243,530,000 | -1.7% | 3,201,394 | +92.4% | 0.56% | +21.7% |
| Q4 2021 | $247,865,000 | – | 1,663,967 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,358,528 | $49,504,760 | 100.00% |
| Meritech Capital Associates V L.L.C. | 1,061,682 | $38,687,692 | 9.44% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $13,102,148 | 4.90% |
| Sands Capital Ventures, LLC | 481,770 | $17,556 | 4.81% |
| Whitford Management LLC | 58,310 | $2,124,803 | 2.88% |
| FINANCIAL CONSULATE, INC | 156,457 | $5,701,293 | 1.99% |
| SRS Investment Management, LLC | 3,005,427 | $109,517,760 | 1.98% |
| BRANDYWINE MANAGERS, LLC | 11,208 | $408,420 | 1.43% |
| ARK Investment Management | 4,316,567 | $157,295,701 | 1.36% |
| Nikko Asset Management Americas, Inc. | 2,177,988 | $79,365,883 | 1.14% |